Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Nuvectis Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nuvectis Pharma Inc. June 13, 202490.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Nuvectis Pharma Inc. | Grant or award | +35,000 | — | — |
| Jun 12, 2025 | TG Therapeutics Inc. | Grant or award | +14,718 | — | — |
| Jun 12, 2025 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Jun 19, 2024 | TG Therapeutics Inc. | Grant or award | +22,250 | — | — |
| Jun 13, 2024 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Sep 28, 2023 | TG Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Jun 16, 2023 | Nuvectis Pharma Inc. | Grant or award | +18,000 | — | — |
Questions about Kenneth Hoberman
What boards is Kenneth Hoberman on?
Kenneth Hoberman sits on the boards of Nuvectis Pharma Inc. and TG Therapeutics Inc.
How long has Kenneth Hoberman served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.